跳至主要内容
临床试验/CTRI/2024/06/069161
CTRI/2024/06/069161招募中2/3 期

A comparative clinical trial to assess the effect of Marichyadi Taila and phototherapy in Mandal Kushtha with special reference to Twak Sharir

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年10月10日最近更新:

试验速览

阶段
2/3 期
状态
招募中
入组人数
40
试验地点
1
主要终点
Changes in PASI Score

研究概览

简要总结

The prevalence of Psoriasis in India as well as globally is quite high. The report of the prevalence of Psoriasis in countries ranges from 0.09% to 11.43% and making Psoriasis a serious global problem with at least 100 million individuals affected worldwide. Prevalence studied from India are mostly hospital-based which is reported to be 8%.  Mandal Kushtha or Psoriasis is difficult to cure as per Ayurveda as well as modern means of treatment. Kushtha or skin diseases are chronic i.e., Kashtasadhya. It affects cosmetically which disturbs the patient from a psychological point of view. Modern medical procedures and treatments have a lot of adverse effects on the Liver, Kidney, Bone marrow, and Skin itself. Apart from this, generally, topical steroids are expensive, and sometimes poor patients cannot afford this treatment. Hence there is a need to search for better methods for the management of Psoriasis.

AIM: -

To assess the effect of Marichyadi Taila and Phototherapy in Mandal Kushtha with special reference to Twak Sharir.

 OBJECTIVE: -

Ø  To study the physio-pathology of Twak Sharir with special reference to Mandal Kushtha.

Ø  To study the effect of Phototherapy on Mandal Kushtha

Ø  To compare the effect of Marichyadi Taila and Phototherapy in Mandal Kushtha with special reference to Twak Sharir.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Subjects with the classical features of Mandal Kushtha.

排除标准

  • Subjects suffering from known cases of other systemic disorders such as Cardiac Problems, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, HIV, HBsAg, Leprosy, etc.
  • Pregnant, lactating mothers.

结局指标

主要结局

Changes in PASI Score

时间窗: 8 weeks

次要结局

  • Changes in classical signs & symptoms of Mandal Kushta(6 weeks)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

DrManoj Kumar Gurawa

National Institute of Ayurveda

研究点 (1)

Loading locations...

相似试验